Pharmaceuticals (Jan 2024)

The Bi-(AID-1-T) G-Quadruplex Has a Janus Effect on Primary and Recurrent Gliomas: Anti-Proliferation and Pro-Migration

  • Svetlana Pavlova,
  • Lika Fab,
  • Ekaterina Savchenko,
  • Anastasia Ryabova,
  • Marina Ryzhova,
  • Alexander Revishchin,
  • Igor Pronin,
  • Dmitry Usachev,
  • Alexey Kopylov,
  • Galina Pavlova

DOI
https://doi.org/10.3390/ph17010074
Journal volume & issue
Vol. 17, no. 1
p. 74

Abstract

Read online

High-grade gliomas are considered an incurable disease. Despite all the various therapy options available, patient survival remains low, and the tumor usually returns. Tumor resistance to conventional therapy and stimulation of the migratory activity of surviving cells are the main factors that lead to recurrent tumors. When developing new treatment approaches, the effect is most often evaluated on standard and phenotypically depleted cancer cell lines. Moreover, there is much focus on the anti-proliferative effect of such therapies without considering the possible stimulation of migratory activity. In this paper, we studied how glioma cell migration changes after exposure to bi-(AID-1-T), an anti-proliferative aptamer. We investigated the effect of this aptamer on eight human glioma cell cultures (Grades III and IV) that were derived from patients’ tumor tissue; the difference between primary and recurrent tumors was taken into account. Despite its strong anti-proliferative activity, bi-(AID-1-T) was shown to induce migration of recurrent tumor cells. This result shows the importance of studying the effect of therapeutic molecules on the invasive properties of glioma tumor cells in order to reduce the likelihood of inducing tumor recurrence.

Keywords